Literature DB >> 20010207

The hazards of hazard ratios.

Miguel A Hernán1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20010207      PMCID： PMC3653612          DOI： 10.1097/EDE.0b013e3181c1ea43

Source DB:  PubMed          Journal:  Epidemiology        ISSN： 1044-3983            Impact factor:   4.822


× No keyword cloud information.
  10 in total

1.  Adjusted survival curves with inverse probability weights.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Comput Methods Programs Biomed       Date:  2004-07       Impact factor: 5.428

2.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

Review 3.  Statistical issues arising in the Women's Health Initiative.

Authors:  Ross L Prentice; Mary Pettinger; Garnet L Anderson
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

4.  Properties of 2 counterfactual effect definitions of a point exposure.

Authors:  W Dana Flanders; Mitchel Klein
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

5.  Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference.

Authors:  S Greenland
Journal:  Epidemiology       Date:  1996-09       Impact factor: 4.822

6.  Structural accelerated failure time models for survival analysis in studies with time-varying treatments.

Authors:  Miguel A Hernán; Stephen R Cole; Joseph Margolick; Mardge Cohen; James M Robins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-07       Impact factor: 2.890

7.  Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Authors:  Sengwee Toh; Sonia Hernández-Díaz; Roger Logan; Jacques E Rossouw; Miguel A Hernán
Journal:  Ann Intern Med       Date:  2010-02-16       Impact factor: 25.391

8.  Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.

Authors:  Miguel A Hernán; Alvaro Alonso; Roger Logan; Francine Grodstein; Karin B Michels; Walter C Willett; Joann E Manson; James M Robins
Journal:  Epidemiology       Date:  2008-11       Impact factor: 4.822

9.  Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States.

Authors:  Yi Zhang; Mae Thamer; Dennis Cotter; James Kaufman; Miguel A Hernán
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

10.  Estrogen plus progestin and the risk of coronary heart disease.

Authors:  JoAnn E Manson; Judith Hsia; Karen C Johnson; Jacques E Rossouw; Annlouise R Assaf; Norman L Lasser; Maurizio Trevisan; Henry R Black; Susan R Heckbert; Robert Detrano; Ora L Strickland; Nathan D Wong; John R Crouse; Evan Stein; Mary Cushman
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245
  10 in total
  279 in total

1.  Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.

Authors:  Wuchao Li; Liwen Zhang; Chong Tian; Hui Song; Mengjie Fang; Chaoen Hu; Yali Zang; Ying Cao; Shiyuan Dai; Fang Wang; Di Dong; Rongpin Wang; Jie Tian
Journal:  Eur Radiol       Date:  2018-12-05       Impact factor: 5.315

2.  Counterpoint: epidemiology to guide decision-making: moving away from practice-free research.

Authors:  Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2015-10-26       Impact factor: 4.897

3.  Deletion diagnostics for the generalised linear mixed model with independent random effects.

Authors:  B Ganguli; S Sen Roy; M Naskar; E J Malloy; E A Eisen
Journal:  Stat Med       Date:  2015-12-02       Impact factor: 2.373

4.  Estimation with Cox models: cause-specific survival analysis with misclassified cause of failure.

Authors:  Bart Van Rompaye; Shabbar Jaffar; Els Goetghebeur
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

5.  Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy.

Authors:  Erin E Gabriel; Peter B Gilbert
Journal:  Biostatistics       Date:  2013-12-13       Impact factor: 5.899

6.  Evidence of a paradoxical relationship between endotoxin and lung cancer after accounting for left truncation in a study of Chinese female textile workers.

Authors:  Katie M Applebaum; Roberta M Ray; George Astrakianakis; Dao Li Gao; David B Thomas; David C Christiani; Michael P LaValley; Wenjin Li; Harvey Checkoway; Ellen A Eisen
Journal:  Occup Environ Med       Date:  2013-06-12       Impact factor: 4.402

7.  Invited commentary: composite outcomes as an attempt to escape from selection bias and related paradoxes.

Authors:  Miguel A Hernán; Enrique F Schisterman; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2013-11-27       Impact factor: 4.897

8.  Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials.

Authors:  Peter B Gilbert; Bryan E Shepherd; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

9.  Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.

Authors:  Adeniyi Francis Fagbamigbe; Emma Norrman; Christina Bergh; Ulla-Britt Wennerholm; Max Petzold
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

10.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.